glutathione neuroprotection brain health benefits Polyphenols and Alzheimer's Disease: A Review on Molecular and Therapeutic Insights With In Silico Support Sulforaphane and Brain Health: From

This suggests that DIDO3 and PHF3 IDRs facilitate clustering with Pol II

Choi J, Liu R-M, Forman HJ

The CuO(2)@G5-BS/TF nanocomplex can target tumor cells overexpressing carbonic anhydrase IX (PC@B-HCAIX) through specific binding with p-carboxybenzenesulfonamide (BS), inhibit their CAIX activity, thereby reducing intracellular pH to accelerate the release of Fe 3+ /Cu 2+ , self-supply of H 2 O 2 , and Fenton reaction

4 weeks 28 half-tablets (14 x 0.5 mg) Half a 0.5 mg tablet per day x 28 days = 14 full tablets 8 weeks 56 half-tablets (28 x 0.5 mg) 28 full 0.5 mg tablets if splitting 12 weeks 84 half-tablets (42 x 0.5 mg) 42 full 0.5 mg tablets if splitting 24 weeks 168 half-tablets (84 x 0.5 mg) Matches the full 24-week 0.25 mg arm of Phase 2/Phase 3 Round up slightly for travel days, dropped tablets, and any schedule changes